VAXX (Vaxxinity) FCF Margin %: 0.00% (As of Dec. 2023)


What is Vaxxinity FCF Margin %?

Vaxxinity VAXX FCF Margin % is 0.00% as of Dec. 2023.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Vaxxinity's Free Cash Flow for the three months ended in Dec. 2023 was $-12.26 Mil. Vaxxinity's Revenue for the three months ended in Dec. 2023 was $0.00 Mil. Therefore, Vaxxinity's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

As of today, Vaxxinity's current FCF Yield % is 0.00%.

The historical rank and industry rank for Vaxxinity's FCF Margin % or its related term are showing as below:


VAXX's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -85.21
* Ranked among companies with meaningful FCF Margin % only.

Vaxxinity FCF Margin % Related Terms

Vaxxinity FCF Margin % Historical Data

* Premium members only.

The historical data trend for Vaxxinity's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vaxxinity FCF Margin % Chart

Vaxxinity Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
FCF Margin %
0.00 -6,353.14 -124,709.09 0.00 0.00

Vaxxinity Quarterly Data
Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

VAXX vs VBIVQ, AMPE, EFTR: FCF Margin % Comparison

For the Biotechnology subindustry, Vaxxinity's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vaxxinity FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vaxxinity's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Vaxxinity's FCF Margin % falls into.


Vaxxinity FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Vaxxinity's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-58.041/0
= %

Vaxxinity's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-12.259/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Vaxxinity (VAXX) has a FCF Margin % of 0.00% as of Dec. 2023. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Vaxxinity and its competitors.
Is Vaxxinity's FCF Margin % too high?
Vaxxinity's current FCF Margin % is 0.00%.
How does Vaxxinity's FCF Margin % compare to VBIVQ and AMPE?
Vaxxinity's FCF Margin % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Vaxxinity and its competitors. Vaxxinity's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vaxxinity stock overvalued right now?
Vaxxinity (VAXX) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Vaxxinity (VAXX), the current FCF Margin % is 0.00% as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vaxxinity Business Description

Address 505 Odyssey Way, Merritt Island, FL, USA, 32953
Vaxxinity Inc is a biotechnology company committed to democratizing healthcare across the globe. The company is pioneering a new class of synthetic, peptide-based active immunotherapy medicines aimed at disrupting the existing treatment paradigm for chronic disease, increasingly dominated by monoclonal antibodies, which suffer from prohibitive costs and cumbersome administration. The company's proprietary technology platform has enabled the innovation of novel pipeline candidates designed to bring the efficiency of vaccines to the treatment of chronic diseases, including Alzheimer's, Parkinson's, migraine, and hypercholesterolemia.